STOK ▼ -0.1% - Stoke Therapeutics, Inc. $STOK Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting 06-OCT-2026 08:04 AM ET